Skip to main content
Premium Trial:

Request an Annual Quote

Andrew Quong

Andrew Quong has joined Fluidigm as the company's first-ever chief science officer. Quong was most recently director of strategic scientific initiatives and partnerships at the Frederick National Laboratory for Cancer Research, a National Cancer Institute-sponsored center. Prior to this, Quong was a faculty member in the Department of Cancer Biology at Thomas Jefferson University and the Department of Oncology at Georgetown University. Quong completed his postdoc at the Naval Research Laboratory as a National Research Council Fellow, and received his PhD in physics from the University of California, Irvine.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.